News
07-20-2015, 05:50 AM
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today the launch of a new line of germline cancer predisposition testing services. The new tests include comprehensive testing for BRCA1 and BRCA2 encompassing an analysis of all exons and adjacent intronic regions.
More... (http://www.news-medical.net/news/20150720/NeoGenomics-announces-launch-of-new-germline-cancer-predisposition-testing-services.aspx)
More... (http://www.news-medical.net/news/20150720/NeoGenomics-announces-launch-of-new-germline-cancer-predisposition-testing-services.aspx)